In terms of change in absolute off time , rotigotine was non - inferior to pramipexole 从绝对关时相的变化上看,罗替戈汀与普拉克索相比并没有劣势。
Continuous delivery of rotigotine as transdermal patches could offer similar efficacy to oral pramipexole in patients with fluctuating parkinson ' s disease over 6 months of treatment 治疗症状波动的帕金森病患者时,持续的给予罗替戈汀透皮贴片贴敷治疗( 6个月以上的治疗)可达到与口服普拉克索治疗相似的疗效。